发明名称 Antibody-light fusion products for cancer therapeutics
摘要 Antibody-LIGHT fusion products or conjugates stimulate immunity against tumors and eradicate metastases. Tumor-specific antibodies coupled with LIGHT effectively target metastatic tumors and reduces cancer metastases.
申请公布号 US9623116(B2) 申请公布日期 2017.04.18
申请号 US201514717808 申请日期 2015.05.20
申请人 The University of Chicago 发明人 Fu Yang-Xin
分类号 A61K39/00;A61K39/395;A61K47/48;C07K14/525;A61K31/7088;A61K38/19 主分类号 A61K39/00
代理机构 Casimir Jones SC 代理人 Casimir Jones SC ;Staple David
主权项 1. A method of reducing the growth of a primary tumor or cancer metastasis in a subject in need thereof, the method comprising: (a) administering to the subject a composition comprising a tumor specific antibody linked to a fragment of a human LIGHT protein to the subject, wherein the LIGHT fragment is resistant to protease digestion and is sufficient to stimulate tumor specific cytotoxic T lymphocytes against the tumor cells; (b) delivering a nucleic acid molecule encoding LIGHT or a fragment thereof to the primary tumor; and (c) stimulating the tumor-specific cytotoxic T-lymphocytes against the tumor or its metastases to reduce to the growth of the primary tumor or cancer metastasis.
地址 Chicago IL US